Trial intelligence / Profile preview

Opium tincture stepwise reduction versus methadone for sexual function in married men with opium dependence

IRCT20261018071471N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Jan 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of opium tincture and methadone in opioid use disorder (OUD) (4 arms), sponsored by Islamic Azad University. Primary endpoints: Treatment readiness, Sexual functioning and 1 more. Started Jan 2026; status: completed.

02

Drugs

opium tincturemethadone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on IRCT20261018071471N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20261018071471N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call